Top Markets
Coin of the day
AcelRx Pharmaceuticals, Inc. AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc.

ACRX
Κατάταξη σε μετοχές #31918
AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily... AcelRx Pharmaceuticals, Inc. is a specialized biopharmaceutical firm primarily dedicated to advancing and bringing to market medical solutions for managing acute pain. The company's key commercial products include DSUVIA and DZUVEO, which are 30 microgram sufentanil tablets administered under the tongue, intended for treating significant short-term pain. AcelRx also develops ZALVISO, a pre-programmed, patient-managed analgesia system that enables hospital patients experiencing moderate-to-severe acute pain to self-administer sufentanil sublingual tablets for their pain relief. In its development pipeline, AcelRx is progressing ARX-02, which is currently in Phase 2 clinical trials, targeting sudden, intense cancer-related pain in individuals who are tolerant to opioid medications. Another candidate, 4ARX-03, is being investigated for its utility in providing mild sedation and pain relief during various medical procedures that might cause discomfort. Beyond acute pain, AcelRx's investigational portfolio features Niyad, a regional anticoagulant designed for use in external blood circulation systems. Furthermore, LTX-608, a nafamostat formulation for direct intravenous infusion, is being explored as an experimental treatment for a range of conditions, including COVID, severe lung injury (acute respiratory distress syndrome), widespread blood clotting (disseminated intravascular coagulation), and acute pancreatitis. The company was founded in 2005 and initially operated under the name SuRx, Inc., before officially rebranding as AcelRx Pharmaceuticals, Inc. in August 2006. It is headquartered in Hayward, California.
Τιμή μετοχής
$0.922
Τελευταίος συγχρονισμός: 2024-02-05
Κεφαλαιοποίηση
$11.68M
Αλλαγή (1 ημέρα)
-1.91%
Αλλαγή (1 έτος)
0.00%
Χώρα
US
Εμπόριο AcelRx Pharmaceuticals, Inc. (ACRX)

Κατηγορία

Ιστορικό τιμής μετοχής για την AcelRx Pharmaceuticals, Inc. (ACRX)
Υψηλότερη τιμή κλεισίματος: $0.97 στις 2024-02-01

Χαμηλότερη τιμή κλεισίματος: $79.56 στις 2011-02-01
Ιστορικό τιμής μετοχής της AcelRx Pharmaceuticals, Inc. από 2011 έως 2026
Ετήσια απόδοση τιμής μετοχής
Έτος Απόδοση
2024 26.40%
2023 -64.67%
2022 -80.39%
2021 -58.51%
2020 -36.98%
2019 -21.96%
2018 30.20%
2017 -27.31%
2016 -34.24%
2015 -32.90%
2014 -31.99%
2013 150.50%
2012 50.28%
2011 0.00%
Τιμή μετοχής για παρόμοιες εταιρείες ή ανταγωνιστές
Εταιρεία Τιμή μετοχής Μεταβολή 1Έτ% Χώρα
$171.67 -
DE
$161.79 25.18%
DE
$37.20 22.61%
JP
$220.05 32.86%
CH
$20.66 10.46%
IN